Thanh Von
Dana-Farber Cancer Institute(US)
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Chronic Myeloid Leukemia Treatments, FOXO transcription factor regulation, Lung Cancer Treatments and Mutations, Ubiquitin and proteasome pathways
Most-Cited Works
- → CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer(2015)484 cited
- → Functional Characterization of an Isoform-Selective Inhibitor of PI3K-p110β as a Potential Anticancer Agent(2012)161 cited
- → MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells(2014)121 cited
- → PI3Kβ controls immune evasion in PTEN-deficient breast tumours(2023)120 cited
- → PI3K isoform dependence of PTEN-deficient tumors can be altered by the genetic context(2014)70 cited
- → Hematopoiesis and RAS-driven myeloid leukemia differentially require PI3K isoform p110α(2014)54 cited
- → A PI3K p110β–Rac signalling loop mediates Pten-loss-induced perturbation of haematopoiesis and leukaemogenesis(2015)48 cited
- → PI3K-p110α mediates resistance to HER2-targeted therapy in HER2+, PTEN-deficient breast cancers(2015)42 cited
- → BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation(2018)26 cited
- → Spatially distinct roles of class Ia PI3K isoforms in the development and maintenance of PTEN hamartoma tumor syndrome(2013)24 cited